Xcout Intel
MEDIOS AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Subscribe to see MEDIOS AG’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MEDIOS AG at a glance
MEDIOS AG is a pharmaceuticals company headquartered in Berlin, Germany. It is publicly listed (ILM1) with a market capitalisation of $323.5M. Xcout tracks 1 named person at MEDIOS AG, including Katrin Neuffer (Director Investor Relations & Communications).
MEDIOS AG leadership
- Katrin NeufferDirector Investor Relations & Communications
Get MEDIOS AG's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on MEDIOS AG in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access